Seres Therapeutics IncSeres Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG rating includes 17 United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. Detailed ESG assessment of Seres Therapeutics Inc are reached by signing in. The report of Seres Therapeutics Inc is assembled by All Street Sevva using cutting edge NLP.

Seres Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 1.6, social score of 3.2 and governance score of 6.7.

SDG Transparency Score for Seres Therapeutics Inc 
Low
0 - 3

4.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Seres Therapeutics Inc 
1.6

Environmental

3.2

Social

6.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1376Vericel Corp
4.2
High
1376vTv Therapeutics Inc
4.2
High
1412Seres Therapeutics Inc
4.1
High
1412Abivax SA
4.1
High
1412Aeglea Bio Therapeutics Inc
4.1
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Seres Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Seres Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Seres Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Seres Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Seres Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Seres Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Seres Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Seres Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Seres Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Seres Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Seres Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Seres Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Seres Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Seres Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Seres Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Seres Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Seres Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Seres Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteria microbiome drug, which is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation and solid organ transplants. In addition, the company engages in the development of SER-287 and SER-301 that are in Phase Ib to treat ulcerative colitis; SER-401 for patients with metastatic melanoma; and SER-262 to treat Clostridioides difficile infection. It has license and collaboration agreements with Nestec Ltd. and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Sorry!

Failed to process!